z-logo
open-access-imgOpen Access
Detecting Novel Urine Biomarkers for the Early Diagnosis of Prostate Cancer: Platelet Derived Growth Factor-BB as a Possible New Target
Author(s) -
Athanasios Skarmoutsos,
Ioannis Skarmoutsos,
Ioannis Katafigiotis,
Elisavet Tataki,
Athina Giagini,
Christos Alamanis,
Ioannis Anastasiou,
Anastasios Angelou,
Mordechai Duvdevani,
Nikolaos M. Sitaras,
Constantinos Constantinides
Publication year - 2018
Publication title -
current urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.476
H-Index - 13
eISSN - 1661-7657
pISSN - 1661-7649
DOI - 10.1159/000447225
Subject(s) - medicine , prostate cancer , urine , receiver operating characteristic , biomarker , prostate specific antigen , prostate biopsy , platelet derived growth factor receptor , prostate , urology , pca3 , cancer , growth factor , pathology , biochemistry , chemistry , receptor
Although the prostate specific antigen revolutionized the diagnosis of prostate cancer (PCa), it has its limitations. We prospectively examined the potential use of the platelet-derived growth factor-BB (PDGF-BB) as a urine biomarker for the early diagnosis of PCa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here